Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This locus is a **pseudogene**, meaning it is a nonfunctional DNA sequence homologous to the parent gene **fatty acyl-CoA reductase 2** (FAR2). Pseudogenes are defined by high sequence homology to functional genes but are incapable of producing a functional protein product[1][3]. While FAR2 is a reductase enzyme involved in fatty acid metabolism and specialized lipid biosynthesis[2][6], this pseudogene does not retain protein-coding capacity and is not a therapeutic target nor implicated in disease biology[1][3]. Like many pseudogenes, it may sometimes be transcribed at low levels, but such transcripts typically have no functional significance in human biology[3][7]. Pseudogenes occasionally complicate experimental designs (e.g., PCR amplification bias) but are not drug targets nor established biomarkers.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of fatty acyl-CoA reductase 2 (ENSG00000284619).